Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
8
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
8
×
national blog main
national top stories
new york blog main
new york top stories
pfizer
8
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
8
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
8
×
cancer immunotherapy
alzheimer's disease
investing
merck
cancer
eli lilly
fda
astrazeneca
bayer
europe blog main
What
bio
roundup
drug
develop
pfizer’s
acquisitions
amid
biggest
bombast
buy
cancer
caught
ceo
companies
coronavirus
crispr
debate
discussion
efforts
growing
meso’s
miss
pandemic
pharmaceutical
presidential
promise
response
tuesday’s
typically
vaccine
viewers
albert
alliance
alzheimer’s
approved
bails
bourla
brand
bridgebio
bristol
Language
unset
unknown
Current search:
pfizer
×
deals
×
" wisconsin top stories "
×
national
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More